Thereby, in general, the more complex the injury, the more complex the healing effect that the BPC 157 therapy realized, the more complex are the requirements to confirm the obtained findings
What is AOD9604 AOD9604 is a peptide that consists of the C-terminal fragment of human growth hormone from amino acids 177-191 with an additional tyrosine residue at the N-terminus of the peptide
BPC-157 is studied across several preclinical domains: angiogenesis and vascular signaling (VEGFR2/eNOS), nitric oxide pathway modulation, tendon and ligament fibroblast migration, muscle-injury recovery, and MAPK/ERK1/2-linked wound-healing signaling
(Frontiers in Pharmacology, 2022) reported pharmacokinetics and tissue distribution in rats and dogs, including a rapid plasma half-life under 30 minutes after IM or IV dosing
Skorjanec, S
But these are not consistently observed